These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21063699)

  • 1. Evidence for metabolic origin of absorptive hypercalciuria Type II.
    Pak CY; Pearle MS; Sakhaee K
    Urol Res; 2011 Apr; 39(2):147-52. PubMed ID: 21063699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dietary calcium on serum 1,25-dihydroxyvitamin D concentrations in renal stone formers.
    D'Amour P; Gascon-Barré M; Dufresne L; Perreault JP
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):549-62. PubMed ID: 6094046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria.
    Heller HJ; Zerwekh JE; Gottschalk FA; Pak CY
    Kidney Int; 2007 Apr; 71(8):808-15. PubMed ID: 17311067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining hypercalciuria in nephrolithiasis.
    Pak CY; Sakhaee K; Moe OW; Poindexter J; Adams-Huet B; Pearle MS; Zerwekh JE; Preminger GM; Wills MR; Breslau NA; Bartter FC; Brater DC; Heller HJ; Odvina CV; Wabner CL; Fordtran JS; Oh M; Garg A; Harvey JA; Alpern RJ; Snyder WH; Peters PC
    Kidney Int; 2011 Oct; 80(7):777-82. PubMed ID: 21775970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of absorptive hypercalciuria type I without the oral calcium load test.
    Pak CY; Sakhaee K; Pearle MS
    J Urol; 2011 Mar; 185(3):915-9. PubMed ID: 21251672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity to calcium intake in calcium stone forming patients.
    Heilberg IP; Martini LA; Draibe SA; Ajzen H; Ramos OL; Schor N
    Nephron; 1996; 73(2):145-53. PubMed ID: 8773335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?
    Tostivint IN; Castiglione V; Alkouri R; Bertocchio JP; Inaoui R; Daudon M; Dousseaux MP; Cavalier E; Pieroni L; Izzedine H
    Urolithiasis; 2022 Oct; 50(5):577-587. PubMed ID: 35994082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.
    Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J
    Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria.
    Preminger GM; Pak CY
    J Urol; 1987 Jun; 137(6):1104-9. PubMed ID: 3586136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.
    Letavernier E; Traxer O; Daudon M; Tligui M; Hubert-Brierre J; Guerrot D; Sebag A; Baud L; Haymann JP
    Clin J Am Soc Nephrol; 2011 May; 6(5):1149-54. PubMed ID: 21441130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypercalciuria].
    Wróblewski T; Wystrychowski A
    Przegl Lek; 2011; 68(2):107-13. PubMed ID: 21751520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
    Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of calcium metabolism in calcium-containing stone formers].
    Ikeda M; Ohmori A
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1313-21. PubMed ID: 7474614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteocalcin response to calcium-restricted diet: a helpful tool for the workup of hypercalciuria.
    Strohmaier WL; Schlee-Giehl K; Bichler KH
    Eur Urol; 1996; 30(1):103-7. PubMed ID: 8854076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and absorptive hypercalciuria: a metabolic disturbance with varying and interchanging modes of expression.
    Aladjem M; Barr J; Lahat E; Bistritzer T
    Pediatrics; 1996 Feb; 97(2):216-9. PubMed ID: 8584380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary protein levels affect the excretion of oxalate and calcium in patients with absorptive hypercalciuria type II.
    Urivetzky M; Motola J; Braverman S; Smith AD
    J Urol; 1987 Apr; 137(4):690-2. PubMed ID: 3560323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dietary modification on urinary stone risk factors.
    Pak CY; Odvina CV; Pearle MS; Sakhaee K; Peterson RD; Poindexter JR; Brinkley LJ
    Kidney Int; 2005 Nov; 68(5):2264-73. PubMed ID: 16221228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights into the pathogenesis of idiopathic hypercalciuria.
    Worcester EM; Coe FL
    Semin Nephrol; 2008 Mar; 28(2):120-32. PubMed ID: 18359393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.